Various unmet needs exist in Multiple Myeloma treatment; Our novel therapy’s early data shows remarkable response: Cyril Konto, President, Ichnos Glenmark Innovation
- Posted on November 26, 2024
- By Financial Express
- 2 Views
Various unmet needs exist in Multiple Myeloma treatment; Our novel therapy’s early data shows remarkable response: Cyril Konto, President, Ichnos Glenmark Innovation
If confirmed in clinical settings, this advantage could position ISB 2001 to leapfrog these approved therapies and expedite its path to frontline treatment for multiple myeloma, Konto told Financial Express.com.
